| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Juliann M Paolicch. The timing of pediatric epilepsy syndromes: what are the developmental triggers? Annals of the New York Academy of Sciences. vol 1304. 2014-02-19. PMID:24279892. |
the neurologic pathways underlying the development of spasms have been identified through pet scans as developmental abnormalities of serotonergic and gabaergic neurotransmitter systems in the brain stem and basal ganglia. |
2014-02-19 |
2023-08-12 |
Not clear |
| Roger F Butterwort. Parkinsonism in cirrhosis: pathogenesis and current therapeutic options. Metabolic brain disease. vol 28. issue 2. 2013-12-16. PMID:23086199. |
the cause of parkinsonism in cirrhosis has been attributed to manganese deposition in basal ganglia structures, leading to the dysfunction of the dopaminergic neurotransmitter system. |
2013-12-16 |
2023-08-12 |
Not clear |
| Andrew H Miller, Ebrahim Haroon, Charles L Raison, Jennifer C Felge. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depression and anxiety. vol 30. issue 4. 2013-10-17. PMID:23468190. |
through their effects on neurotransmitter systems, cytokines impact neurocircuits in the brain including the basal ganglia and anterior cingulate cortex, leading to significant changes in motor activity and motivation as well as anxiety, arousal, and alarm. |
2013-10-17 |
2023-08-12 |
Not clear |
| Gail D Tillman, Clifford S Calley, Timothy A Green, Virginia I Buhl, Melanie M Biggs, Jeffrey S Spence, Richard W Briggs, Robert W Haley, Michael A Kraut, John Har. Visual event-related potentials as markers of hyperarousal in Gulf War illness: evidence against a stress-related etiology. Psychiatry research. vol 211. issue 3. 2013-09-09. PMID:23149040. |
although many factors may contribute to p3b amplitude differences - most notably depression and poor sleep quality, symptoms that are prevalent in the gw syndrome groups - our findings in context of previous studies on this population are consistent with the contention that dysfunction in cholinergic and dopaminergic neurotransmitter systems, and in white matter and basal ganglia may be contributing to impairments in gw veterans. |
2013-09-09 |
2023-08-12 |
Not clear |
| Andrew H Moberly, Lindsey A Czarnecki, Joseph Pottackal, Tom Rubinstein, Daniel J Turkel, Marley D Kass, John P McGan. Intranasal exposure to manganese disrupts neurotransmitter release from glutamatergic synapses in the central nervous system in vivo. Neurotoxicology. vol 33. issue 5. 2013-03-21. PMID:22542936. |
this is the first direct evidence that mn intoxication can disrupt neurotransmitter release, and is consistent with previous work suggesting that chronic mn exposure limits amphetamine-induced dopamine increases in the basal ganglia despite normal levels of dopamine synthesis (guilarte et al., j neurochem 2008). |
2013-03-21 |
2023-08-12 |
mouse |
| Andrew H Moberly, Lindsey A Czarnecki, Joseph Pottackal, Tom Rubinstein, Daniel J Turkel, Marley D Kass, John P McGan. Intranasal exposure to manganese disrupts neurotransmitter release from glutamatergic synapses in the central nervous system in vivo. Neurotoxicology. vol 33. issue 5. 2013-03-21. PMID:22542936. |
the commonality of mn's action between glutamatergic neurons in the olfactory bulb and dopaminergic neurons in the basal ganglia suggests that a disruption of neurotransmitter release may be a general consequence wherever mn accumulates in the brain and could underlie its pleiotropic effects. |
2013-03-21 |
2023-08-12 |
mouse |
| Guillermo Aquino-Miranda, Anayansi Molina-Hernández, José-Antonio Arias-Montañ. [Regulation by histamine H3 receptors of neurotransmitter release in the basal ganglia: implications for Parkinson's disease pathophysiology]. Gaceta medica de Mexico. vol 148. issue 5. 2013-02-26. PMID:23128888. |
[regulation by histamine h3 receptors of neurotransmitter release in the basal ganglia: implications for parkinson's disease pathophysiology]. |
2013-02-26 |
2023-08-12 |
Not clear |
| J E Yuste, M B Echeverry, F Ros-Bernal, A Gomez, C M Ros, C M Campuzano, E Fernandez-Villalba, M T Herrer. 7-Nitroindazole down-regulates dopamine/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson's disease. Neuropharmacology. vol 63. issue 7. 2013-02-12. PMID:22877786. |
this new evidence suggests a prominent role for nitric oxide in the neurotransmitter balance within the basal ganglia in the pathophysiology of experimental parkinsonism. |
2013-02-12 |
2023-08-12 |
rat |
| U Havemann, K Kuschinsk. Neurochemical aspects of the opioid-induced 'catatonia'. Neurochemistry international. vol 4. issue 4. 2012-10-02. PMID:20487869. |
in this review, the symptoms contributing to the opioid-induced 'catatonia' are presented in detail, and efforts are made to relate these symptoms to opioid-induced alterations in neurotransmitter metabolism in several parts of brain, in particular in the basal ganglia. |
2012-10-02 |
2023-08-12 |
Not clear |
| S Hecker. Neural models of schizophrenia. Dialogues in clinical neuroscience. vol 2. issue 3. 2012-09-10. PMID:22033839. |
the key anatomical systems in higher-order information processing are the cortex, thalamus, basal ganglia, and medial temporal lobe, each of which is modulated by neurotransmitter projection systems. |
2012-09-10 |
2023-08-12 |
Not clear |
| Noriaki Koshikawa, Satoshi Fujita, Kazunori Adach. Behavioral pharmacology of orofacial movement disorders. International review of neurobiology. vol 97. 2011-10-25. PMID:21708305. |
by using such methods, the involvement of neurotransmitter systems and functional neural connections within the basal ganglia has been studied in rat rhythmical jaw movements. |
2011-10-25 |
2023-08-12 |
rat |
| D Dardou, D Dassesse, L Cuvelier, T Deprez, M De Ryck, S N Schiffman. Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system. Brain research. vol 1367. 2011-04-15. PMID:20869353. |
altogether, our results suggest that sv2c may contribute to the regulation of neurotransmitter release and synaptic transmission in the basal ganglia including cholinergic striatal interneurons and nigro-striatal/mesolimbic dopamine neurons. |
2011-04-15 |
2023-08-12 |
mouse |
| Carrie Brienne Hurelbrink, Simon John Geoffrey Lewi. Pathological considerations in the treatment of Parkinson's disease: more than just a wiring diagram. Clinical neurology and neurosurgery. vol 113. issue 1. 2011-04-14. PMID:20828923. |
nevertheless, there are multiple symptoms that are unresponsive to any of these therapies, highlighting the involvement of other neurotransmitter systems and the complexities of the disease beyond the basal ganglia circuitry. |
2011-04-14 |
2023-08-12 |
Not clear |
| Priyantha Herath, Cecile Gallea, Jan Willem van der Veen, Silvina G Horovitz, Mark Hallet. In vivo neurochemistry of primary focal hand dystonia: a magnetic resonance spectroscopic neurometabolite profiling study at 3T. Movement disorders : official journal of the Movement Disorder Society. vol 25. issue 16. 2011-04-08. PMID:20979122. |
the purpose of this study was to assess the differences of the inhibitory neurotransmitter, gamma amino butyric acid (gaba), in the sensorimotor cortex and the basal ganglia using magnetic resonance spectroscopy with optimized gaba sensitivity. |
2011-04-08 |
2023-08-12 |
Not clear |
| Yan Xu, Zhentao Zhang, Kairong Qin, Stella M Papa, Xuebing Ca. Quantitative autoradiographic study on receptor regulation in the basal ganglia in rat model of levodopa-induced motor complications. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban. vol 29. issue 2. 2011-03-17. PMID:19399396. |
in order to study neurotransmitter receptor regulation in the basal ganglia involved in the functional changes underlying levodopa-induced motor complications, quantitative autoradiography was used to observe receptor bindings of dopamine d1 and d2, n-methyl-d-aspartate (nmda), amino-3-hydroxy-5-methylisoxazole propionic acid (ampa) and amino butyric acid (gaba) in the basal ganglia of rats that had unilateral nigrostriatal lesions and had been chronically treated with levodopa until motor complications developed. |
2011-03-17 |
2023-08-12 |
rat |
| William M Connelly, Jan M Schulz, George Lees, John N J Reynold. Differential short-term plasticity at convergent inhibitory synapses to the substantia nigra pars reticulata. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 44. 2010-12-08. PMID:21048144. |
these findings highlight the importance of differential dynamics of neurotransmitter release in regulating the circuit behavior of the basal ganglia. |
2010-12-08 |
2023-08-12 |
Not clear |
| Andrej Bartolić, Zvezdan Pirtosek, Janez Rozman, Samo Ribari. Tremor amplitude and tremor frequency variability in Parkinson's disease is dependent on activity and synchronisation of central oscillators in basal ganglia. Medical hypotheses. vol 74. issue 2. 2010-04-15. PMID:19656636. |
while rigidity, bradykinesia and postural instability can be explained with changes in neurotransmitter concentrations and neuronal activity in basal ganglia, the pathogenesis of parkinsonian tremor is not fully understood. |
2010-04-15 |
2023-08-12 |
Not clear |
| M C Y de Wit, I F M de Coo, D J J Halley, M H Lequin, G M S Mancin. Movement disorder and neuronal migration disorder due to ARFGEF2 mutation. Neurogenetics. vol 10. issue 4. 2009-12-07. PMID:19384555. |
we hypothesize that the movement disorder and the preferential damage to the basal ganglia, specifically to the putamen, may be caused by an increased sensitivity to degeneration, a dynamic dysfunction due to neurotransmitter receptor mislocalization or a combination of both. |
2009-12-07 |
2023-08-12 |
Not clear |
| Nicola Palomero-Gallagher, Hans-Jürgen Bidmon, Markus Cremer, Axel Schleicher, Gerald Kircheis, Guido Reifenberger, George Kostopoulos, Dieter Häussinger, Karl Zille. Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. vol 24. issue 3-4. 2009-11-16. PMID:19710544. |
neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy. |
2009-11-16 |
2023-08-12 |
human |
| Monika Meyer-Baron, Guido Knapp, Michael Schäper, Christoph van Thrie. Performance alterations associated with occupational exposure to manganese--a meta-analysis. Neurotoxicology. vol 30. issue 4. 2009-10-27. PMID:19465050. |
the evidence of cognitive and motor performance effects is in accordance with the knowledge about accumulation of manganese in the basal ganglia and the effect of manganese on the neurotransmitter dopamine. |
2009-10-27 |
2023-08-12 |
Not clear |